Saturday 17 October 2026
Export ZBH’s income statement to Excel — free account
Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.
95.06
0.68
+0.72%
Follow ZBH
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
67.33 | 13.24 | 0.00 | 26.37 | 0.00 | 63.91 | 115.71 | 24.72 | 23.74 | 25.19 |
Piotroski F-Score |
5 | 6 | 5 | 7 | 3 | 7 | 5 | 8 | 6 | 6 |
P/S ratio |
2.62 | 3.12 | 2.58 | 3.73 | 5.05 | 3.77 | 3.84 | 3.43 | 2.79 | 2.16 |
Altman Z-Score |
1.64 | 2.00 | 1.94 | 2.59 | 2.49 | 2.53 | 2.97 | 3.01 | 2.86 | 2.38 |
Altman Z″-Score (non-manufacturers) |
2.40 | 2.70 | 2.76 | 3.09 | 3.10 | 3.31 | 3.74 | 3.96 | 4.25 | 3.96 |
P/FCF ratio |
18.21 | 22.33 | 15.66 | 36.76 | 61.12 | 26.30 | 30.60 | 28.94 | 27.41 | 16.53 |
Beneish M-Score |
(2.59) | (2.51) | (3.07) | (2.43) | (2.57) | (2.72) | (2.62) | (2.54) | (2.59) | (2.59) |
P/Operating CF |
31.99 | 60.36 | 54.00 | 70.41 | 104.55 | 76.21 | 109.25 | 43.06 | 42.37 | 34.41 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 72 |
P/B ratio |
2.07 | 2.07 | 1.82 | 2.41 | 2.54 | 2.03 | 2.22 | 2.03 | 1.72 | 1.40 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
4.00 | 4.35 | 3.64 | 4.69 | 6.25 | 4.75 | 4.61 | 4.15 | 3.53 | 3.00 |
EV/EBITDA |
16.22 | 15.47 | 14.06 | 16.90 | 25.79 | 17.87 | 16.71 | 13.76 | 11.89 | 11.28 |
EV/Operating CF |
18.79 | 21.45 | 16.53 | 23.59 | 35.60 | 23.09 | 23.59 | 19.40 | 18.10 | 14.57 |
EV/FCF |
27.83 | 31.15 | 22.08 | 46.13 | 75.57 | 33.14 | 36.70 | 35.05 | 34.67 | 22.96 |
Quick Ratio |
0.94 | 0.67 | 0.75 | 0.58 | 0.88 | 0.47 | 0.75 | 0.65 | 0.82 | 0.89 |
Current Ratio |
1.96 | 1.49 | 1.83 | 1.37 | 1.99 | 1.41 | 1.88 | 1.61 | 1.91 | 1.98 |
Net Debt/EBITDA |
5.61 | 4.38 | 4.09 | 3.43 | 4.93 | 3.69 | 2.78 | 2.40 | 2.49 | 3.16 |
Debt/Assets |
42.13% | 38.99% | 37.05% | 33.37% | 33.28% | 30.14% | 27.04% | 26.83% | 29.04% | 32.56% |
Debt/Equity |
1.16 | 0.86 | 0.79 | 0.66 | 0.67 | 0.56 | 0.47 | 0.46 | 0.50 | 0.59 |
Asset Turnover |
0.28 | 0.30 | 0.32 | 0.33 | 0.25 | 0.29 | 0.31 | 0.35 | 0.36 | 0.37 |
Operating CF/Net income |
5.34 | 0.87 | (4.61) | 1.40 | (7.74) | 3.50 | 5.86 | 1.54 | 1.66 | 2.41 |
Capex/Depreciation |
(0.50) | (0.35) | (0.22) | (0.67) | (0.26) | (0.45) | (0.39) | (0.74) | (0.60) | (0.53) |
Interest Coverage |
2.31 | 2.46 | 0.12 | 5.01 | 0.39 | 4.13 | 4.23 | 6.35 | 5.90 | 3.75 |
| 3.13% | 16.95% | (3.30%) | 9.56% | (1.13%) | 3.23% | 1.87% | 8.35% | 7.24% | 5.60% | |
| 1.14% | 6.88% | (1.51%) | 4.64% | (0.57%) | 1.68% | 1.04% | 4.81% | 4.22% | 3.17% | |
ROIC |
2.53% | 2.34% | 0.11% | 3.56% | 0.27% | 2.78% | 2.51% | 4.48% | 4.43% | 3.50% |
Return on Tangible Assets |
7.08% | 51.33% | (9.43%) | 33.68% | (3.04%) | 12.34% | 5.87% | 26.86% | 21.17% | 14.87% |
Average Days of Receivables |
76.37 | 72.23 | 58.70 | 62.37 | 86.53 | 67.34 | 72.66 | 71.20 | 70.38 | 75.58 |
Research and Development Expense of Revenue |
4.77% | 4.74% | 4.94% | 5.63% | 5.27% | 6.38% | 5.85% | 6.20% | 5.70% | 5.57% |
Selling, General and Administrative Expense of Revenue |
38.40% | 39.79% | 42.60% | 41.89% | 44.27% | 41.65% | 39.79% | 38.39% | 38.16% | 39.57% |
Intangible Assets out of Total Assets |
0.73 | 0.73 | 0.72 | 0.68 | 0.67 | 0.62 | 0.65 | 0.64 | 0.63 | 0.64 |
Share Based Compensation of Revenue |
0.75% | 0.69% | 0.83% | 1.06% | 1.20% | 1.11% | 1.51% | 1.35% | 1.32% | 1.10% |
Graham Net Nets |
(0.62) | (0.40) | (0.41) | (0.25) | (0.23) | (0.23) | (0.17) | (0.17) | (0.20) | (0.30) |
Graham Number |
40.26 | 109.09 | 0.00 | 86.55 | 0.00 | 51.35 | 37.69 | 81.31 | 78.43 | 71.79 |
Earnings Yield |
1.49% | 7.56% | (1.84%) | 3.79% | (0.45%) | 1.56% | 0.86% | 4.04% | 4.21% | 3.97% |
Free Cash Flow Yield |
5.49% | 4.48% | 6.38% | 2.72% | 1.64% | 3.80% | 3.27% | 3.46% | 3.65% | 6.05% |
Revenue per Share |
38.34 | 38.65 | 38.98 | 38.92 | 29.60 | 32.73 | 33.11 | 35.43 | 37.81 | 41.57 |
Operating CF per Share |
8.16 | 7.84 | 8.59 | 7.73 | 5.20 | 6.73 | 6.47 | 7.58 | 7.38 | 8.57 |
Capex per Share |
(2.65) | (2.44) | (2.16) | (3.51) | (1.79) | (2.04) | (2.27) | (3.38) | (2.94) | (2.92) |
Free Cash Flow per Share |
5.51 | 5.40 | 6.43 | 4.22 | 3.40 | 4.69 | 4.20 | 4.19 | 4.44 | 5.66 |
Cash per Share |
3.17 | 2.60 | 2.67 | 3.01 | 3.87 | 1.81 | 1.79 | 1.99 | 2.59 | 2.99 |
Shareholders Equity per Share |
48.35 | 58.13 | 55.41 | 60.42 | 58.93 | 60.72 | 57.38 | 59.84 | 61.43 | 64.17 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
48.35 | 58.13 | 55.41 | 60.42 | 58.93 | 60.72 | 57.38 | 59.84 | 61.43 | 64.17 |
Free Cash Flow |
1,102.00 | 1,089.30 | 1,308.40 | 865.20 | 704.30 | 978.70 | 880.30 | 875.40 | 902.30 | 1,119.70 |
Working Capital |
2,282.10 | 1,495.10 | 2,006.10 | 1,282.40 | 2,526.40 | 1,417.10 | 2,069.10 | 1,752.10 | 2,220.60 | 2,536.20 |
Capital Expenditures |
(530.20) | (493.00) | (439.00) | (720.60) | (371.30) | (425.60) | (475.90) | (706.20) | (597.10) | (577.40) |
Net Current Asset Value |
(12,350.90) | (9,713.70) | (8,423.30) | (7,522.00) | (7,135.00) | (5,905.00) | (4,611.70) | (4,399.20) | (4,217.60) | (5,266.10) |
EV/EBIT |
37.35 | 42.46 | 854.69 | 32.89 | 460.79 | 37.68 | 45.96 | 24.02 | 21.10 | 22.52 |
Capex to Sales |
0.07 | 0.06 | 0.06 | 0.09 | 0.06 | 0.06 | 0.07 | 0.10 | 0.08 | 0.07 |
Price to Operating Income |
24.44 | 30.43 | 606.29 | 26.20 | 372.65 | 29.91 | 38.31 | 19.83 | 16.69 | 16.21 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.53 | 0.68 | 1.00 | 0.52 | 0.68 | 0.52 | 0.65 | 0.46 | 0.49 | 0.50 |
Cash ROIC |
5.11% | 4.86% | 6.30% | 4.07% | 3.33% | 4.87% | 4.86% | 4.69% | 4.70% | 5.38% |
Accounts Receivable Turnover |
5.03 | 4.96 | 5.63 | 6.05 | 4.35 | 5.03 | 5.26 | 5.24 | 5.25 | 5.17 |
Accounts Payable Turnover |
7.34 | 6.14 | 6.56 | 5.90 | 4.99 | 6.16 | 6.11 | 5.45 | 7.24 | 10.02 |
Inventory Turnover |
1.13 | 1.06 | 1.05 | 0.97 | 0.75 | 0.85 | 0.94 | 0.92 | 0.95 | 1.10 |
Average Days of Payables |
55.86 | 56.51 | 58.25 | 64.96 | 66.03 | 57.07 | 64.00 | 71.92 | 32.42 | 44.35 |
Days of Inventory on Hand |
300.27 | 353.95 | 362.53 | 386.45 | 490.33 | 399.93 | 388.08 | 417.79 | 372.35 | 334.66 |
Average Receivables |
1,525.45 | 1,574.25 | 1,409.95 | 1,319.85 | 1,408.30 | 1,356.15 | 1,320.55 | 1,411.95 | 1,461.55 | 1,592.55 |
Average Payables |
324.65 | 347.35 | 346.40 | 381.75 | 365.45 | 318.25 | 330.30 | 382.35 | 302.60 | 248.80 |
Average Inventory |
2,106.75 | 2,013.85 | 2,162.40 | 2,320.75 | 2,417.85 | 2,299.35 | 2,147.60 | 2,266.20 | 2,310.25 | 2,260.85 |
Average Assets |
26,922.50 | 26,349.20 | 25,070.40 | 24,382.75 | 24,528.20 | 23,937.05 | 22,261.20 | 21,281.45 | 21,431.10 | 22,228.50 |
Average Common Equity |
9,779.65 | 10,702.70 | 11,505.80 | 11,834.45 | 12,296.10 | 12,432.90 | 12,346.70 | 12,257.60 | 12,482.20 | 12,591.00 |
Columns are period end dates